Localization in the A1 loop (AA 509-695) of von Willebrand factor of eight new mutations responsible for type 2A or 2M von Willebrand disease

被引：0
|
作者：
Lavergne, JM
Fressinaud, E
Gaucher, C
Ribba, AS
Derlon, A
JuhanVague, I
Goudemand, J
ParquetGernez, A
Lelouche, F
Ledford, M
Mazurier, C
Meyer, D
机构：
[1] HOP BICETRE, INSERM, NETWORK MOL ABNORMALAT VON WILLEBRAND DIS, PARIS, FRANCE
[2] HOP BICETRE, INSERM U143, PARIS, FRANCE
[3] LFB, LAB RECH HEMOSTASE, LILLE, FRANCE
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：P2669 / P2669
页数：1
相关论文
共 50 条
  • [31] Dominant von Willebrand Disease Type 2M and 2U Are Variable Expressions of One Distinct Disease Entity Caused by Loss-of-Function Mutations in the A1 Domain of the von Willebrand Factor Gene
    Gadisseur, Alain
    van der Planken, Marc
    Schroyens, Wilfried
    Berneman, Zwi
    Michiels, Jan Jacques
    [J]. ACTA HAEMATOLOGICA, 2009, 121 (2-3) : 145 - 153
  • [32] Expression studies of von Willebrand factor missense mutations causing type 1 or type 2 von Willebrand disease (VWD)
    Yadegari, H.
    Driesen, J.
    Hambitzer, P.
    Pavlova, A.
    Oldenburg, J.
    [J]. HAEMOPHILIA, 2012, 18 : 195 - 196
  • [33] Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease
    Casonato, Alessandra
    Gallinaro, Lisa
    Pontara, Elena
    Bernardo, Letizia
    Sartorello, Francesca
    Daidone, Viviana
    Pagnan, Antonio
    [J]. THROMBOSIS RESEARCH, 2007, 120 (03) : 451 - 453
  • [34] Type 2M von Willebrand disease caused by a novel Q1402P substitution in the botrocetin binding site of the von Willebrand factor A1 domain.
    Kroner, PA
    Gill, JC
    Haberichter, SL
    Bellissimo, DB
    Buchholz, N
    Desai, DL
    Montgomery, RR
    [J]. BLOOD, 2003, 102 (11) : 543A - 544A
  • [35] DDAVP treatment in a child with von Willebrand disease type 2M
    C. Mauz-Körholz
    U. Budde
    D. Körholz
    U. Göbel
    [J]. European Journal of Pediatrics, 1999, 158 : S174 - S176
  • [36] DDAVP treatment in a child with von Willebrand disease type 2M
    Mauz-Körholz, C
    Budde, U
    Körholz, D
    Göbel, U
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1999, 158 (Suppl 3) : S174 - S176
  • [37] Identification and Functional Analysis of a Novel von Willebrand Factor Mutation in a Family with Type 2A von Willebrand Disease
    Dong, Jing
    Zhao, Xiaojuan
    Shi, Sensen
    Ma, Zhenni
    Liu, Meng
    Wu, Qingyu
    Ruan, Changgeng
    Dong, Ningzheng
    [J]. PLOS ONE, 2012, 7 (03):
  • [38] Identification and functional studies of a novel von Willebrand factor mutation in a family with type 2A von Willebrand disease
    Dong, J.
    Zhao, X.
    Wu, Q.
    Ruan, C.
    Dong, N.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 664 - 664
  • [39] P.E1549K: a new mutation responsible of von willebrand disease type 2M
    Woods, A., I
    Sanchez-Luceros, A.
    Kempfer, A. C.
    Bermejo, E., I
    Calderazzo, J. C.
    Blanco, A. N.
    Meschengieser, S. S.
    Lazzari, M. A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 102 - 102
  • [40] Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations
    Rastegar-Lari, G
    Ajzenberg, N
    Ribba, AS
    Vereycken-Holler, V
    Legendre, P
    Villoutreix, BO
    Meyer, D
    Baruch, D
    [J]. THROMBOSIS AND HAEMOSTASIS, 2001, 86 (06) : 1459 - 1465
12345